These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37450381)

  • 1. Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.
    Hisada Y; Kawano T; Archibald SJ; Welch JS; Reeves BN; Mackman N
    Blood Adv; 2023 Sep; 7(18):5458-5469. PubMed ID: 37450381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.
    Zhao H; Sun J; Yan L; Jin B; Hou W; Cao F; Li H; Zhou J; Zhang Y
    Ann Hematol; 2021 Jun; 100(6):1473-1483. PubMed ID: 33893844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
    Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
    Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia.
    Nakasaki T; Wada H; Mori Y; Okugawa Y; Watanabe R; Nishikawa M; Gabazza EC; Masuya M; Kageyama S; Kumeda K; Kato H; Shiku H
    Am J Hematol; 2000 Jul; 64(3):145-50. PubMed ID: 10861807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
    Ma G; Liu F; Lv L; Gao Y; Su Y
    Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of Microparticles Derived from Acute Promyelocytic Leukemia Cells in Coagulopathy].
    Zhang YM; Chen B; Wu LY; Hou JX; Fu JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):693-698. PubMed ID: 28641620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
    Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
    J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated hemostasis in acute promyelocytic leukemia.
    Hisada Y
    Int J Hematol; 2024 May; 119(5):526-531. PubMed ID: 38341391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents.
    Zhu J; Guo WM; Yao YY; Zhao WL; Pan L; Cai X; Ju B; Sun GL; Wang HL; Chen SJ; Chen GQ; Caen J; Chen Z; Wang ZY
    Leukemia; 1999 Jul; 13(7):1062-70. PubMed ID: 10400422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
    Wu F; Wang X; Zhao W; Wang H; Shen Z
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
    Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
    Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia.
    Cao M; Li T; He Z; Wang L; Yang X; Kou Y; Zou L; Dong X; Novakovic VA; Bi Y; Kou J; Yu B; Fang S; Wang J; Zhou J; Shi J
    Blood; 2017 Mar; 129(13):1855-1864. PubMed ID: 28053193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
    Tallman MS; Hakimian D; Kwaan HC; Rickles FR
    Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
    Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
    Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin.
    Lavallée VP; Chagraoui J; MacRae T; Marquis M; Bonnefoy A; Krosl J; Lemieux S; Marinier A; Pabst C; Rivard GÉ; Hébert J; Sauvageau G
    Leukemia; 2018 Jun; 32(6):1349-1357. PubMed ID: 29550835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.
    Avvisati G; ten Cate JW; Sturk A; Lamping R; Petti MG; Mandelli F
    Br J Haematol; 1988 Sep; 70(1):43-8. PubMed ID: 2460126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia.
    Iversen PO; Sørensen DR; Sioud M
    Thromb Haemost; 2010 Aug; 104(2):350-4. PubMed ID: 20539915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.
    Wang P; Zhang Y; Yang H; Hou W; Jin B; Hou J; Li H; Zhao H; Zhou J
    Hematology; 2018 Dec; 23(10):756-764. PubMed ID: 29724147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
    Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
    Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.